← Back to Patent Explorer
US4397843A Expired / Lapsed US ⏱️ 0.0 years remaining

Mannose-6-phosphate-low density protein reagent effective against hypercholesterolemia

Assignee: United States Department of Health and Human Services
•
Filing: 1982-01-21
•
Granted: 1983-08-09
•
Expires: 2002-01-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A new reagent effective in inhibiting cholesterol synthesis 75% in human fibroblasts derived from patients suffering from the disease familial hypercholestrolemia is Man6P-low density lipoprotein and is effective in tissue culture test systems at 100 μg/ml after a ten-hour exposure. The broad purpose of this invention is to modify the receptor specificity of a protein so that it will enter cells which were previously impermeable and exert new effects or reverse a pathological condition. That is, the compound of this invention is a useful reagent in the selective cytotoxic treatment of hypercholesterolemia.

Inventors

  • 👤 David M. Neville, Jr.
  • 👤 Richard J. Youle
  • 👤 Gary J. Murray

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:51
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/415; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/61; A61K47/68; A61K47/6801; A61K47/6803; A61K47/6811; A61K47/6817; A61K47/6819; A61K47/6821; A61K47/6823; C07K14/435; C07K14/775; A61K38/00

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 14 words
A reagent for treating familial hypercholestrolemia comprising an effective amount of mannose-6-phosphate-low density lipoprotein.
Claim 2
Dependent Claim 14 words
A reagent for treating familial hypercholestrolemia comprising an effective amount of mannose-6-phosphate-low density lipoprotein.
Claim 3
Dependent Claim 14 words
A cholesterol synthesis inhibiting reagent composition comprising an effective amount of mannose-6-phosphate-low density protein.
Claim 4
Dependent Claim 14 words
A cholesterol synthesis inhibiting reagent composition comprising an effective amount of mannose-6-phosphate-low density protein.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-08 1987-02-07 1987-08-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-08 1991-02-07 1991-08-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-08 1995-02-07 1995-08-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag